Omega-3 supplementation can shorten hospital stay for post-op gastrointestinal cancer patients: Review

By Cheryl Tay contact

- Last updated on GMT

The incidence of infectious complications was significantly different between the omega-3 and control groups. ©iStock
The incidence of infectious complications was significantly different between the omega-3 and control groups. ©iStock

Related tags: Omega-3 fatty acid, Nutrition, Fatty acid

Parenteral omega-3 fatty acid supplementation can benefit gastrointestinal cancer patients after operations, according to researchers in China.

Reseachers at China's Shandong University conducted a review to determine the effects of parenteral nutrition with omega-3 supplementation on immune function and clinical outcomes in post-operative gastrointestinal cancer patients.

They assessed seven RCTs involving a total of 457 participants. Of the seven trials, five (involving 373 participants) "indicated that the incidence of infectious complications was significantly different between the (omega-3) intervention and control groups"​.

In addition, five trials involving 385 participants showed that parenteral omega-3 fatty acid supplementation significantly reduced the duration of hospitalisation for post-operative gastrointestinal cancer patients.

The researchers also said omega-3 might be able to affect inflammatory response outcome — possibly through "leukocyte–endothelial interactions by oxidised omega-3 fatty acids" ​— and the production of inflammatory mediators.

Critical illness limitations

However, they stated there was insufficient evidence that parenteral nutrition with omega-3 supplementation had any significant impact on mortality, infectious complications, and duration of ICU stay for critically ill patients.

They said the review had found parenteral omega-3 supplementation beneficial to post-operative gastrointestinal cancer patients in terms of immune function and clinical outcomes, adding that these findings may be able to support the clinical application of omega-3 fatty acid supplementation.

They concluded: "However, these partial results should be treated with caution because of the limitations of and potential risk of bias in the included studies.

"Large-scale, randomised, prospective trials are warranted to assess the effect of parenteral omega-3 fatty acid supplementation in postoperative gastrointestinal cancer patients."

 

Source: Asia Pacific Journal of Clinical Nutrition

https://doi.org/10.6133/apjcn.022017.19

"Effects of parenteral ω-3 fatty acid supplementation in postoperative gastrointestinal cancer on immune function and length of hospital stay: a systematic review and meta-analysis"

Authors: Hao Bai, et al.

Related news

Show more

Related products

show more

Organic Maritech® Fucoidan: The Evidence

Organic Maritech® Fucoidan: The Evidence

Marinova Pty. Ltd. | 13-Aug-2018 | Technical / White Paper

Fucoidans are highly bioactive polysaccharides found in brown seaweed that protect from water-borne pathogens and environmental challenges. This white...

The most studied extract of a precious fruit: bilberry

The most studied extract of a precious fruit: bilberry

Indena: the botanical ingredient of Health Food industry | 07-Aug-2018 | Application Note

Plants represent a rich source of active principles that can be used in different markets including health foods and supplements. The overall quality is...

Exploring Fibre Fermentation Profiles

Exploring Fibre Fermentation Profiles

Tate and Lyle | 27-Apr-2018 | Technical / White Paper

ProDigest developed the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®), which explores the fermentation profiles of fibres and evaluates...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars